Respirix
San Francisco, US · Founded 2015 · Delaware corporation
Find your way into Respirix
Sign up to see every warm intro you have to Respirix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Respirix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
EK

EL
Evan LuxonNamed on SEC filing
DB
Daniel BurnettNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 1 round · 2018
▶$1.3MraisedAug 2019 · 90 investors · Other Health CareRule 506(c)
▶$1.3MraisedAug 2019 · 90 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Eric KriegsteinExecutive Officer, Director
- Evan LuxonExecutive Officer, Director
- Daniel BurnettExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.3M
- Minimum investment
- $200
- Sales commissions
- $47.3K
- Placement agents
- SI Securities, LLC
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Respirix raised?
- Respirix has disclosed $1.3M raised across 1 round.
- Where is Respirix headquartered?
- Respirix is headquartered in San Francisco, US.